Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence
- 30 June 1995
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 169 (6) , 595-599
- https://doi.org/10.1016/s0002-9610(99)80228-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A lingitudinal studyCancer, 1991
- CA72–4: A new tumour marker for gastric cancerBritish Journal of Surgery, 1990
- Comparison of CA 72–4 with CA 19–9 and Carcinoembryonic Antigen in the Serodiagnostics of Gastrointestinal MalignanciesScandinavian Journal of Gastroenterology, 1989
- Serum Levels of Carcinoembryonic Antigen, Gastrointestinal Cancer-Associated Antigen and Alphafetoprotein in Staging and Management of Patients with Advanced Carcinoma of the StomachThe International Journal of Biological Markers, 1987
- Measurement of a monoclonal-antibody-defined antigen (CA 19-9) in the sera of patients with malignant and nonmalignant diseases comparison with carcinoembryonic antigenCancer, 1985
- Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bankInternational Journal of Cancer, 1984
- Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.Journal of Clinical Pathology, 1984
- Klinische Bedeutung des zirkulierenden tumorassoziierten Antigens CA 19-9 bei Karzinomen des VerdauungstraktesDeutsche Medizinische Wochenschrift (1946), 1984
- Prognostic value of preoperative serum CEA level compared to clinical staging: Ii. Stomach cancerBritish Journal of Cancer, 1982